<DOC>
	<DOCNO>NCT01446003</DOCNO>
	<brief_summary>This study evaluate effect treatment multiple dose MK-8457 systolic blood pressure participant mild moderate hypertension .</brief_summary>
	<brief_title>A Study Effect MK-8457 Blood Pressure Hypertensive Participants ( MK-8457-004-AM1 )</brief_title>
	<detailed_description />
	<criteria>If female , must nonchildbearing potential If male female partner ( ) childbearing potential must agree use medically acceptable method contraception study 90 day last dose study drug Body mass index ( BMI ) â‰¤35 kg/m^2 Mildtomoderate hypertension require treatment one antihypertensive agent Receiving stable treatment hypertension least 8 week prior start dose continue therapy duration study No clinically significant arrhythmia clinically significant abnormality electrocardiogram Nonsmoker and/or use nicotine nicotinecontaining product least approximately 6 month Any illness might confound result study pose additional risk History stroke , chronic seizure , major neurological disorder Clinically significant endocrine , gastrointestinal , hematological , hepatic , immunological , renal , respiratory , genitourinary abnormality diseases Clinically significant cardiovascular disease active angina History malignant neoplastic disease Taking 325 mg aspirin daily Taking 3 medication treatment hypertension Unable refrain anticipates use nonsteroidal antiinflammatory drug ( NSAIDs ) Consumes excessive amount alcohol and/or coffee , tea , cola , caffeinated beverage Has major surgery , donate lose 1 unit blood participate another investigational study within 4 week Significant multiple and/or severe allergy Regular user illicit drug history drug ( include alcohol ) abuse within approximately 2 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>